Future Financial Wealth Managment LLC Takes Position in Sabra Health Care REIT, Inc. (NASDAQ:SBRA)

Future Financial Wealth Managment LLC acquired a new position in shares of Sabra Health Care REIT, Inc. (NASDAQ:SBRA) during the 1st quarter, according to its most recent disclosure with the SEC. The institutional investor acquired 6,000 shares of the real estate investment trust’s stock, valued at approximately $89,000.

A number of other large investors have also recently made changes to their positions in SBRA. Tennessee Valley Asset Management Partners purchased a new position in shares of Sabra Health Care REIT during the fourth quarter worth approximately $25,000. GAMMA Investing LLC purchased a new stake in Sabra Health Care REIT during the fourth quarter valued at approximately $33,000. Neo Ivy Capital Management purchased a new position in Sabra Health Care REIT during the 4th quarter worth $41,000. Principal Securities Inc. purchased a new position in shares of Sabra Health Care REIT in the 4th quarter valued at approximately $46,000. Finally, Newbridge Financial Services Group Inc. purchased a new position in shares of Sabra Health Care REIT in the fourth quarter worth $56,000. 99.40% of the stock is currently owned by institutional investors.

Insider Transactions at Sabra Health Care REIT

In related news, Director Catherine Cusack acquired 7,000 shares of the company’s stock in a transaction on Wednesday, May 22nd. The shares were purchased at an average price of $14.43 per share, for a total transaction of $101,010.00. Following the purchase, the director now owns 46,385 shares in the company, valued at $669,335.55. The acquisition was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Corporate insiders own 1.10% of the company’s stock.

Analysts Set New Price Targets

Several research analysts recently issued reports on SBRA shares. Wedbush reissued an “outperform” rating and set a $17.00 target price on shares of Sabra Health Care REIT in a report on Thursday, February 29th. Scotiabank increased their price objective on shares of Sabra Health Care REIT from $14.00 to $15.00 and gave the company a “sector perform” rating in a report on Wednesday, May 15th. Finally, Truist Financial increased their price objective on Sabra Health Care REIT from $15.00 to $16.00 and gave the company a “buy” rating in a research note on Thursday. Six analysts have rated the stock with a hold rating and seven have issued a buy rating to the stock. Based on data from MarketBeat.com, Sabra Health Care REIT currently has a consensus rating of “Moderate Buy” and an average price target of $15.79.

Sabra Health Care REIT Price Performance

SBRA opened at $15.12 on Friday. The company has a debt-to-equity ratio of 0.89, a quick ratio of 4.33 and a current ratio of 4.33. The company has a market capitalization of $3.50 billion, a P/E ratio of 75.60, a PEG ratio of 2.37 and a beta of 1.22. Sabra Health Care REIT, Inc. has a 1-year low of $11.57 and a 1-year high of $15.12. The company has a 50-day moving average of $14.34 and a 200-day moving average of $14.10.

Sabra Health Care REIT Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, May 31st. Investors of record on Monday, May 20th were issued a dividend of $0.30 per share. This represents a $1.20 dividend on an annualized basis and a yield of 7.94%. The ex-dividend date was Friday, May 17th. Sabra Health Care REIT’s payout ratio is currently 600.00%.

About Sabra Health Care REIT

As of September 30, 2023, Sabra's investment portfolio included 377 real estate properties held for investment (consisting of (i) 240 Skilled Nursing/Transitional Care facilities, (ii) 43 senior housing communities (Senior Housing – Leased), (iii) 61 senior housing communities operated by third-party property managers pursuant to property management agreements (Senior Housing – Managed), (iv) 18 Behavioral Health facilities and (v) 15 Specialty Hospitals and Other facilities), 12 investments in loans receivable (consisting of two mortgage loans and 10 other loans), five preferred equity investments and two investments in unconsolidated joint ventures.